Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Pacira BioSciencesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Cadence Pharmaceuticals with 1 complete response letter and 1 drug recall. The most recent is a drug recall dated Jul 24, 2012: OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL….
| Jul 24, 2012 | OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL Vials per carton, Rx only, Manufactured for…Class II · Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter. | Drug recall |
| Feb 10, 2010 | Complete response letter, NDA 022450Approved | Complete response letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.